Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Print: 0893-9675
ISSN Online: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2017020550
pages 403-410

Gene Fusions in Human Cancers: A Review Focused on Diagnostic Biomarkers, Method Selections, and Treatments

Hao Ni
Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China; Department of Pathology, Jinling Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China
Xiao-Tong Wang
Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China; Department of Pathology, Jinling Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China
Ru Fang
Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China
Xiao-Jun Zhou
Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China; Department of Pathology, Jinling Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China
Qiu Rao
Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China; Department of Pathology, Jinling Clinical Medical College, Nanjing Medical University, Nanjing, Jiangsu, China

ABSTRACT

Recurrent gene fusions in cancers have been successfully applied in clinical diagnoses and treatments. Specific gene rearrangements or other specific cytogenetic translocations may be helpful in separating cancers from benign lesions. Also, the detection of gene fusions has brought great benefits to distinguish molecular subclassifications of cancers. Numerous approaches have been used to identify cancer-specific abnormalities, including FISH, RT-PCR, next-generation sequencing, etc. In addition to diagnostic and genetic values, molecular testing has been becoming a valuable tool in the therapeutic research. Recent clinical trials involving gene fusions in cancers have also been developing under a rapid speed. Generally, we review gene fusions in cancers, emphasizing on relevant diagnostic biomarkers, method selections, and treatments.


Articles with similar content:

Toward an Understanding of the Molecular Genetics of Prostate Cancer Progression
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 1
Marijana Lijovic, Albert G. Frauman
Cancer Stem Cells in Urooncology
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Cag Cal, Zeynep Yuce
siRNA: A Potential Tool for Future Breast Cancer Therapy?
Critical Reviews™ in Oncogenesis, Vol.12, 2006, issue 1-2
Eirik Frengen, Tone Ikdahl Andersen, Charles M. Perou, Gro Leite Storvold
The Impacts of miRNAs in Glioblastoma Progression
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 2
Rasime Kalkan, Emine İkbal Atli
DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 1-2
Igor Koturbash, Isabelle R. Miousse, Robert J. Griffin, Laura E. Ewing, Kristy R. Kutanzi